Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/11/2026 | Q4 | $7B | -- | -- | -- | -- |
| 10/22/2025 | Q3 | $7.1B | $7.2B | -- | -- | -- |
| 07/23/2025 | Q2 | $7.2B | $14.8B | -- | -- | -- |
| 05/07/2025 | Q1 | $6.8B | $6.9B | -- | -- | -- |
| 02/11/2025 | Q4 | $6.1B | $6.4B | $1.35 | -- | -- |
| 11/06/2024 | Q3 | $6.5B | $6.7B | $1.69 | -- | -- |
| 07/24/2024 | Q2 | $6.6B | $7B | -- | -- | -- |
| 05/07/2024 | Q1 | $6.4B | $6.9B | -- | -- | -- |
| 02/05/2024 | Q4 | $6.1B | $6.4B | $1.76 | -- | -- |
| 09/30/2023 | Q3 | -- | $6.5B | $1.42 | -- | -- |
| 06/30/2023 | Q2 | -- | $6.6B | $1.32 | -- | -- |
| 05/05/2023 | Q1 | -- | $6.4B | -- | -- | -- |
| 12/31/2022 | Q4 | -- | $6.1B | $1.26 | -- | -- |
| 11/11/2022 | Q3 | -- | $4.9B | $0.86 | -- | -- |
| 08/05/2022 | Q2 | -- | $5.2B | $1.03 | -- | -- |
| 05/05/2022 | Q1 | -- | $5.6B | $0.13 | -- | -- |
| 01/28/2022 | Q4 | -- | $5.2B | -$0.46 | -- | -- |
| 11/11/2021 | Q3 | -- | $5.2B | $0.56 | -- | -- |
| 08/05/2021 | Q2 | -- | $5.4B | $0.54 | -- | -- |
| 05/06/2021 | Q1 | -- | $5.6B | $0.48 | -- | -- |
| 02/11/2021 | Q4 | -- | $5.2B | -$0.69 | -- | -- |
| 11/05/2020 | Q3 | -- | $4.9B | $0.22 | -- | -- |
| 08/06/2020 | Q2 | -- | $4.4B | -$1.73 | -- | -- |
| 05/07/2020 | Q1 | -- | $4.8B | -$1.33 | -- | -- |
| 02/06/2020 | Q4 | -- | -- | -$0.48 | -- | -- |
| 11/07/2019 | Q3 | -- | -- | $0.55 | -- | -- |
| 08/07/2019 | Q2 | -- | -- | $0.90 | -- | -- |
| 05/09/2019 | Q1 | -- | -- | $0.60 | -- | -- |
| 02/07/2019 | Q4 | -- | -- | $0.95 | -- | -- |
| 11/08/2018 | Q3 | -- | -- | $0.02 | -- | -- |
| 08/07/2018 | Q2 | -- | -- | $0.55 | -- | -- |
| 05/10/2018 | Q1 | -- | -- | $0.61 | -- | -- |
| 02/08/2018 | Q4 | -- | -- | $0.41 | -- | -- |
| 11/08/2017 | Q3 | -- | -- | -- | -- | -- |
| 08/03/2017 | Q2 | -- | -- | $0.47 | -- | -- |
| 05/10/2017 | Q1 | -- | -- | $0.43 | -- | -- |
| 02/09/2017 | Q4 | -- | -- | -$11.97 | -- | -- |
| 11/10/2016 | Q3 | -- | -- | $0.40 | -- | -- |
| 08/03/2016 | Q2 | -- | -- | $0.78 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | $0.38 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | $0.05 | -- | -- |
UniCredit SpA reported $7.2B worth of top line sales in its most recent quarter.
UniCredit SpA announced earnings per share of -- which represents a miss of analyst forecast a -- per share.
UniCredit SpA reported -- that represents -- per share over the last quarter.
UniCredit SpA's earnings are forecast to grow from $6.42 per share to -- per share next year representing an increase of --.
UniCredit SpA's next earnings date is February 11, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.